U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide. Lyon (FR): International Agency for Research on Cancer; 1999. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 71.)

Cover of Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide

Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide.

Show details

cis-9,10-Epoxystearic acid

Data were last reviewed in IARC (1976) and the compound was classified in IARC Monographs Supplement 7 (1987).

1. Exposure Data

1.1. Chemical and physical data

1.1.1. Nomenclature

  • Chem. Abst. Serv. Reg. No.: 2443-39-2
  • Systematic name: cis-3-Octyl-oxiraneoctanoic acid

1.1.2. Structural and molecular formulae and relative molecular mass

Image 1443a

1.1.3. Physical properties (for details, see IARC, 1976)

  • (a) Melting-point: 59.5–59.8°C
  • (b) Conversion factor: mg/m3 = 12.29 × ppm

1.2. Production and use

cis-9,10-Epoxystearic acid is produced only in small quantities for research purposes, but it can occur in seed oils (e.g., sunflower) upon prolonged storage (IARC, 1976).

2. Studies of Cancer in Humans

No data were available to the working group.

3. Studies of Cancer in Experimental Animals

cis-9,10-Epoxystearic acid was tested for carcinogenicity in mice by skin application and subcutaneous injection, and in rats by subcutaneous injection. No significant increase in the incidence of tumours was associated with treatment (IARC, 1976).

4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms

4.1. Absorption, distribution, metabolism and excretion

4.1.1. Humans

9,10-Epoxystearic acid has been detected in human urine at concentrations of about 2 nmol/L (Ulsaker & Teien, 1995), probably occurring as a result of the oxidation of unsaturated fatty acid by cytochrome P450 (Laniado-Schwartzman et al., 1988).

4.1.2. Experimental systems

No data were available to the Working Group.

4.2. Toxic effects

4.2.1. Humans

No data were available to the Working Group.

4.2.2. Experimental systems

Daily oral doses of cis-9,10-epoxystearic acid of up to 250 mg/kg bw administered by gavage to male and female Sprague-Dawley rats did not affect growth rate, food consumption, organ weights, haematology, blood chemistry or histology. Deaths which occurred during the experiment were not substance-related, but the result of mechanical injury during dosing (Chu et al., 1980).

4.3. Reproductive and developmental effects

No data were available to the Working Group.

4.4. Genetic and related effects

4.4.1. Humans

No data were available to the Working Group.

4.4.2. Experimental data (see Table 1 for references)

Table 1. Genetic and related effects of cis-9,10-epoxystearic acid.

Table 1

Genetic and related effects of cis-9,10-epoxystearic acid.

cis-9,10-Epoxystearic acid was not mutagenic in Salmonella typhimurium in the presence or in the absence of exogenous metabolic activation.

5. Evaluation

No epidemiological data relevant to the carcinogenicity of cis-9,10-epoxystearic acid were available.

There is inadequate evidence in experimental animals for the carcinogenicity of cis-9,10-epoxystearic acid.

Overall evaluation

cis-9,10-Epoxystearic acid is not classifiable as to its carcinogenicity to humans (Group 3).

6. References

  • Chu I., Villeneuve D.C., Nestmann E.R., Douglas G., Becking G.C., Lough R., Matula T.I. Subacute toxicity and mutagenicity of cis-9,10-epoxystearic acid. Bull. environ. Contam. Toxicol. 1980;25:400–403. [PubMed: 7426789]
  • IARC (1976) IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, Vol. 11, Cadmium, Nickel, Some Epoxides, Miscellaneous Industrial Chemicals and General Considerations on Volatile Anaesthetics, Lyon, pp. 153–156. [PubMed: 992654]
  • IARC (1987) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, Lyon, p. 63. [PubMed: 3482203]
  • Laniado-Schwartzman M., Davis K.L., McGiff J.C., Levere R.D., Abraham N.G. Purification and characterization of cytochrome P-450-dependent arachidonic acid epoxygenase from human liver. J. biol. Chem. 1988;263:2536–2542. [PubMed: 3123495]
  • Ulsaker G.A., Teien G. Identification of 9,10-epoxyoctadecanoic acid in human urine using gas chromatography-mass spectrometry. Biomed. Chromatogr. 1995;9:183–187. [PubMed: 8520208]
©International Agency for Research on Cancer, 1999.
Bookshelf ID: NBK499342

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (4.1M)

Related information

Similar articles in PubMed

  • Review Hexamethylphosphoramide.[IARC Monogr Eval Carcinog Risk...]
    Review Hexamethylphosphoramide.
    . IARC Monogr Eval Carcinog Risks Hum. 1999; 71 Pt 3(PT 3):1465-81.
  • Dichloroacetonitrile.[IARC Monogr Eval Carcinog Risk...]
    Dichloroacetonitrile.
    . IARC Monogr Eval Carcinog Risks Hum. 1999; 71 Pt 3(PT 3):1375-9.
  • Review 1,1-Dimethylhydrazine.[IARC Monogr Eval Carcinog Risk...]
    Review 1,1-Dimethylhydrazine.
    . IARC Monogr Eval Carcinog Risks Hum. 1999; 71 Pt 3(PT 3):1425-36.
  • Review Dichloroacetylene.[IARC Monogr Eval Carcinog Risk...]
    Review Dichloroacetylene.
    . IARC Monogr Eval Carcinog Risks Hum. 1999; 71 Pt 3(PT 3):1381-7.
  • Review beta-Propiolactone.[IARC Monogr Eval Carcinog Risk...]
    Review beta-Propiolactone.
    . IARC Monogr Eval Carcinog Risks Hum. 1999; 71 Pt 3(PT 3):1103-18.
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...